Revvity (RVTY) Cost of Revenue (2009 - 2026)
Revvity's (RVTY) quarterly Cost of Revenue came in at $312.8 million in Q3 2026, down 4.55% on a YoY basis from $327.7 million in Q3 2025, and down 3.29% quarter-over-quarter from $323.5 million in Q2 2026.
Analysis
Revvity (RVTY) Cost of Revenue (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Cost of Revenue for 18 consecutive years, with $312.8 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Cost of Revenue fell 4.55% year-over-year to $312.8 million; the trailing twelve-month figure through Jul 2026 stood at $1.1 billion (up 7.45% YoY), and the FY2025 full-year result was $1.1 billion, up 7.24% from the prior year.
- Cost of Revenue retreated to $312.8 million in Q3 2026 per RVTY's latest filing, from $323.5 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $368.4 million in Q2 2022 and bottomed at $140.7 million in Q1 2023.
- Historically, Cost of Revenue has averaged $279.5 million across 5 years, with a median of $302.0 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue slumped 36.69% in 2022, then advanced 27.43% in 2023.
- Over 5 years, Cost of Revenue stood at $304.8 million in 2022, then plunged by 41.17% to $179.3 million in 2023, then fell by 21.1% to $141.5 million in 2024, then gained by 24.3% to $175.8 million in 2025, then surged by 77.9% to $312.8 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $312.8 million, $323.5 million, and $175.8 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 3.65 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 2.65 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 836.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 389.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 312.82 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 109.80 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 305.20 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 94.09 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 38.54 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 422.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 312.82 Mn |
| Apr 5, 2026 | 323.46 Mn |
| Dec 28, 2025 | 175.84 Mn |
| Sep 28, 2025 | 324.35 Mn |
| Jun 29, 2025 | 327.73 Mn |
| Mar 30, 2025 | 289.22 Mn |
| Dec 29, 2024 | 141.46 Mn |
| Sep 29, 2024 | 299.23 Mn |
| Jun 30, 2024 | 306.18 Mn |
| Mar 31, 2024 | 294.87 Mn |
| Dec 31, 2023 | 179.29 Mn |
| Oct 1, 2023 | 298.22 Mn |
| Jul 2, 2023 | 306.74 Mn |
| Apr 2, 2023 | 293.50 Mn |
| Jan 1, 2023 | 140.70 Mn |
| Oct 2, 2022 | 304.76 Mn |
| Jul 3, 2022 | 343.93 Mn |
| Apr 3, 2022 | 368.42 Mn |
| Oct 3, 2021 | 338.45 Mn |
| Jul 4, 2021 | 543.28 Mn |